L01FX Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
45 active ingredients 45 principios activos 45 个活性成分 45 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Amivantamab
L01FX18active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Ipilimumab
L01FX04active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Enfortumab Vedotin
L01FX13active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Epcoritamab
L01FX27active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Tremelimumab
L01FX20active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Sacituzumab Govitecan
L01FX17active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Elranatamab
L01FX32active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Polatuzumab Vedotin
L01FX14active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Glofitamab
L01FX28active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Talquetamab
L01FX29active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Teclistamab
L01FX24active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Zolbetuximab
L01FX31active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Brentuximab Vedotin
L01FX05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Gemtuzumab Ozogamicin
L01FX02active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Loncastuximab Tesirine
L01FX22active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Mosunetuzumab
L01FX25active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES TW EU · unknown HK - Belantamab Mafodotin
L01FX15active US GB CA ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES TW EU · unknown AU HK - Elotuzumab
L01FX08active US GB AU ES TW · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB AU ES TW EU · discontinued CA · unknown HK - Tarlatamab
L01FX33active GB CA SG TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active GB CA SG TW EU · discontinued ES · unknown AU HK - Tafasitamab
L01FX12active US GB CA AU ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU ES TW EU · unknown HK - Blinatumomab
L01FX07active GB CA AU SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active GB CA AU SG ES TW EU · unknown HK - Mogamulizumab
L01FX09active US GB CA AU SG · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU SG ES TW EU - Mirvetuximab Soravtansine
L01FX26active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES TW EU · unknown AU - Datopotamab Deruxtecan
L01FX35active US SG MX TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active US SG MX TW EU · discontinued ES · unknown AU HK - Dinutuximab Beta
L01FX06active GB ES TW EU · and 3 more y 3 más 另有 3 个 另有 3 個
active GB ES TW EU · unknown AU HK - Tisotumab Vedotin
L01FX23active US GB EU · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB EU · discontinued ES · unknown HK - Catumaxomab
L01FX03active GB EU · and 3 more y 3 más 另有 3 个 另有 3 個
active GB EU · discontinued CA ES - Olaratumab
L01FX10active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · withdrawn EU - Linvoseltamab
L01FXactive US EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US EU · discontinued ES - Dinutuximab
L01FX06active US CA · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA · withdrawn EU - Odronextamab
L01FX34active EU · and 2 more y 2 más 另有 2 个 另有 2 個
active EU · discontinued ES - Naxitamab
L01FX21active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · unknown HK - 塔奎妥单抗
L01FXactive CN
active CN - 维恩妥尤单抗
L01FXactive CN
active CN - 莫妥珠单抗
L01FXactive CN
active CN - 埃纳妥单抗
L01FXactive CN
active CN - 特立妥单抗
L01FXactive CN
active CN - 佐妥昔单抗
L01FXactive CN
active CN - 那西妥单抗
L01FXactive CN
active CN - 戈沙妥珠单抗
L01FXactive CN
active CN - 维泊妥珠单抗
L01FXactive CN
active CN - 依沃西单抗
L01FXactive CN
active CN - 索米妥昔单抗
L01FXactive CN
active CN - 莫格利珠单抗
L01FXactive CN
active CN - 芦康沙妥珠单抗
L01FXactive CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).